US BANCORP \DE\ - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 61 filers reported holding REDHILL BIOPHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q3 2022$0
-100.0%
7020.0%0.00%
Q2 2022$1,000
-50.0%
7020.0%0.00%
Q1 2022$2,0000.0%7020.0%0.00%
Q4 2021$2,000
-33.3%
7020.0%0.00%
Q3 2021$3,000
+200.0%
702
+312.9%
0.00%
Q4 2020$1,0000.0%170
+56.0%
0.00%
Q3 2020$1,0001090.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Ibex Investors LLC 444,301$2,284,0001.33%
683 Capital Management, LLC 999,232$5,136,0000.43%
DAFNA Capital Management LLC 35,000$180,0000.10%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$2,164,0000.08%
Migdal Insurance & Financial Holdings Ltd. 397,324$2,042,0000.05%
Claret Asset Management Corp 42,522$219,0000.05%
Orbimed Advisors 564,900$2,904,0000.04%
Altshuler Shaham Ltd 169,446$251,0000.04%
Virtu Financial LLC 60,787$312,0000.02%
MEITAV INVESTMENT HOUSE LTD 48,000$244,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders